Showing 1 - 8 results of 8 for search 'Katarzyna Wiktorska', query time: 0.04s Refine Results
  1. 1
    Synergistic Interaction between 5-FU and an Analog of Sulforaphane—2-Oxohexyl Isothiocyanate—In an In Vitro Colon Cancer Model

    Synergistic Interaction between 5-FU and an Analog of Sulforaphane—2-Oxohexyl Isothiocyanate—In an In Vitro Colon Cancer Model by Małgorzata Milczarek, Anna Pogorzelska, Katarzyna Wiktorska

    Published 2021-05-01
    Get full text
    Article
  2. 2
    Breast Cancer Prevention-Is there a Future for Sulforaphane and Its Analogs?

    Breast Cancer Prevention-Is there a Future for Sulforaphane and Its Analogs? by Dominika Kuran, Anna Pogorzelska, Katarzyna Wiktorska

    Published 2020-05-01
    Get full text
    Article
  3. 3
    In Vitro Evaluation of Sulforaphane and a Natural Analog as Potent Inducers of 5-Fluorouracil Anticancer Activity

    In Vitro Evaluation of Sulforaphane and a Natural Analog as Potent Inducers of 5-Fluorouracil Anticancer Activity by Małgorzata Milczarek, Lidia Mielczarek, Katarzyna Lubelska, Aleksandra Dąbrowska, Zdzisław Chilmonczyk, Dariusz Matosiuk, Katarzyna Wiktorska

    Published 2018-11-01
    Get full text
    Article
  4. 4
    Anticancer effect and safety of doxorubicin and nutraceutical sulforaphane liposomal formulation in triple-negative breast cancer (TNBC) animal model

    Anticancer effect and safety of doxorubicin and nutraceutical sulforaphane liposomal formulation in triple-negative breast cancer (TNBC) animal model by Anna Pogorzelska, Maciej Mazur, Marta Świtalska, Joanna Wietrzyk, Dawid Sigorski, Krzysztof Fronczyk, Katarzyna Wiktorska

    Published 2023-05-01
    Get full text
    Article
  5. 5
    An Organofluorine Isoselenocyanate Analogue of Sulforaphane Affects Antimetabolite 5-Fluorouracil’s Anticancer Activity: A Perspective for New Combinatory Therapy in Triple-Negative Breast Cancer

    An Organofluorine Isoselenocyanate Analogue of Sulforaphane Affects Antimetabolite 5-Fluorouracil’s Anticancer Activity: A Perspective for New Combinatory Therapy in Triple-Negativ... by Małgorzata Milczarek, Tomasz Cierpiał, Piotr Kiełbasiński, Milena Małecka-Giełdowska, Marta Świtalska, Joanna Wietrzyk, Maciej Mazur, Katarzyna Wiktorska

    Published 2023-08-01
    Get full text
    Article
  6. 6
    Insight on the Interaction between the Camptothecin Derivative and DNA Oligomer Mimicking the Target of Topo I Inhibitors

    Insight on the Interaction between the Camptothecin Derivative and DNA Oligomer Mimicking the Target of Topo I Inhibitors by Wojciech Bocian, Beata Naumczuk, Magdalena Urbanowicz, Jerzy Sitkowski, Elżbieta Bednarek, Katarzyna Wiktorska, Anna Pogorzelska, Ewelina Wielgus, Lech Kozerski

    Published 2022-10-01
    Get full text
    Article
  7. 7
    The Mode of SN38 Derivatives Interacting with Nicked DNA Mimics Biological Targeting of Topo I Poisons

    The Mode of SN38 Derivatives Interacting with Nicked DNA Mimics Biological Targeting of Topo I Poisons by Wojciech Bocian, Beata Naumczuk, Magdalena Urbanowicz, Jerzy Sitkowski, Anna Bierczyńska-Krzysik, Elżbieta Bednarek, Katarzyna Wiktorska, Małgorzata Milczarek, Lech Kozerski

    Published 2021-07-01
    Get full text
    Article
  8. 8
    The Comparison of MTT and CVS Assays for the Assessment of Anticancer Agent Interactions.

    The Comparison of MTT and CVS Assays for the Assessment of Anticancer Agent Interactions. by Lidia Śliwka, Katarzyna Wiktorska, Piotr Suchocki, Małgorzata Milczarek, Szymon Mielczarek, Katarzyna Lubelska, Tomasz Cierpiał, Piotr Łyżwa, Piotr Kiełbasiński, Anna Jaromin, Anna Flis, Zdzisław Chilmonczyk

    Published 2016-01-01
    Get full text
    Article

Search Tools: